Revvity reported $275.33M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Agilent USD 475M 10M Jun/2026
Align Technology USD 410.55M 52.12M Sep/2026
Bio Techne USD 67.42M 41.91M Jun/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Bruker USD 226.5M 12.4M Sep/2026
Celltrion KRW 12.72B 3.4B Jun/2026
Charles River Laboratories USD 140.59M 88.31M Sep/2026
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Danaher USD 2.16B 87M Sep/2026
Dentsply International USD 363M 1000K Sep/2026
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 13.56M 1.09M Jun/2026
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Edwards Lifesciences USD 560.9M 300K Sep/2026
Illumina USD 281M 8M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
IQVIA Holdings USD 569M 5M Sep/2026
Kangmei Pharma CNY 253.72M 16.66M Jun/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Laboratory Of America USD 611.4M 34.2M Sep/2026
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Mesa Laboratories USD 27.31M 380K Sep/2024
Mettler Toledo International USD 267.16M 3.82M Sep/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Organigram Holdings CAD 26.51M 4.5M Jun/2026
Ovoca Bio EUR 617K 15K Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Pharma Mar EUR 15.53M 1.59M Sep/2026
Qiagen NV USD 142.33M 60K Jun/2026
Quest Diagnostics USD 523M 6M Sep/2026
Quidel USD 182.7M 7M Sep/2026
Repligen USD 83.59M 6.97M Sep/2026
Revvity USD 275.33M 3.25M Sep/2026
Sartorius EUR 216.6M 4.7M Sep/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Tilray USD 24.85M 1.7M Sep/2025
Waters USD 398M 7M Sep/2026
Zealand Pharma A/S 104M 12.19M Mar/2026
Zz Pientze Pharmaceu CNY 267.85M 44.71M Sep/2026